The fourth branch of the Provincial Food and Drug Administration held a symposium on the implementation of integrated operation of drug batch and zero

In order to promote the implementation of the "policy of benefiting enterprises" in the jurisdiction, the fourth branch of the Provincial Food and Drug Administration recently held a symposium on the implementation of the integrated operation of drug batch and zero, conveying and interpreting to enterprises the policies and drug regulatory requirements on the integrated operation of drug wholesale and retail in the "Several Measures for Further Innovative Supervision and Promoting the High-quality Development of the Drug Circulation Industry", effectively responding to the concerns of enterprises, understanding the needs of enterprises, and alleviating the confusion of enterprises. 31 representatives of 29 enterprises in Yanwei area attended the forum.

At the meeting, the fourth sub-bureau focused on answering the tax policies, medical insurance regulations, and handling of enterprise merger and reorganization procedures involved in the approval of zero-zero integrated operation, and fully communicated with the representatives of participating enterprises, pooled wisdom and efforts to analyze the pros and cons, solve the specific problems of enterprises in the implementation process, and provide enterprises with a realistic theoretical basis and practical cases, so that enterprises can choose a business model conducive to their own development in the future based on their own conditions, and promote the process of the implementation of integrated wholesale and retail operation in the jurisdiction.

Representatives of participating enterprises unanimously agreed that the implementation of integrated operation of drug wholesale and retail will reduce the operating costs of enterprises, improve the efficiency and level of quality management of pharmaceutical business, and better ensure the safety of drug circulation, which is a real "policy to benefit enterprises", and the implementation of this policy has greatly enhanced the confidence and determination of enterprises in the development prospects of themselves and even Shandong pharmaceutical industry.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW